Anti-NY-ESO-1 autoantibody may be a tumor marker for intrahepatic cholangiocarcinoma

Anti-NY-ESO-1 antibody is observed in a multitude of malignancies. This study was aimed to evaluate the expression of serum anti-NY-ESO-1 antibodies and its prognostic value in intrahepatic cholangiocarcinoma. A total of 103 patients with intrahepatic cholangiocarcinoma were enrolled in the study. E...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Zhen, Li, Fan-Fan, Lu, Ming-Dian, Zhang, Shang-Xin, Li, Yong-Xiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5732727/
https://www.ncbi.nlm.nih.gov/pubmed/29262561
http://dx.doi.org/10.18632/oncotarget.22464

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5732727/
https://www.ncbi.nlm.nih.gov/pubmed/29262561
http://dx.doi.org/10.18632/oncotarget.22464

Ejemplares similares